It has been 10 years since the first biosimilar was approved by the FDA. The grades on how the market for biosimilars has developed are...

The FDA approved Avtozma, a tocilizumab biosimilar developed by Celltrion, for the treatment of several rheumatic conditions.

On this special episode of Not So Different honoring Global Biosimilars Week, Craig Burton, executive director of the Biosimilars...

Biologics are regulated by the FDA and are approved under the 351(a) pathway with a Biologics License Application (BLA).

issues affecting payer uptake and provider adoption of biosimilars in the US, such as economic considerations, clinical evidence, and market